Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07226258 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Phase III Study to Assess the Safety and Efficacy of SL1002 for Osteoarthritis Knee Pain

StatusRecruiting
PhasePhase 3
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Study sites: 21 to 22v8
  2. Site contacts updated at 1 of 21 sitesv7
  3. Study sites: 20 to 21v6
  4. Study sites: 18 to 20v5
  5. Study sites: 13 to 18v4
Show 2 earlier versionsHide 2 earlier versions
  1. Site contacts updated at 1 of 13 sites
    • Eligibility criteria shortened, about 2 words
    v3
  2. Study sites: 11 to 13v2
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
A Randomized, Double-Blind, Placebo-Controlled, Single Dose Study to Assess the Safety and Efficacy of SL1002 for the Treatment of Knee Pain in Patients with Osteoarthritis of the Knee.
Trial Details
NCT Number NCT07226258
Lead Sponsor Saol Therapeutics Inc
Conditions
(from sponsor)		 Osteoarthritis Knee Pain
Enrollment 150 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov